Dicerna Pharmaceuticals

-$1.14 (-4.24%) Today
$0.00 (0.00%) As of 8:01 PM UTC after-hours

Why Robinhood?

You can buy or sell DRNA and other stocks, options, and ETFs commission-free!

About DRNA

Dicerna Pharmaceuticals, Inc. Common Stock, also called Dicerna Pharmaceuticals, is a biopharmaceutical company, which engages in discovering, developing and commercializing medicines that are designed to leverage ribonucleic acid interference (RNAi) to selectively silence genes that cause or contribute to disease.

CEO
Douglas M. Fambrough
Employees
302
Headquarters
Lexington, Massachusetts
Founded
2006

DRNA Key Statistics

Market Cap
1.96B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
812.50K
High Today
$26.70
Low Today
$25.65
Open Price
$26.36
Volume
549.22K
52 Week High
$32.67
52 Week Low
$16.50

DRNA Earnings

-$0.58
-$0.20
$0.17
$0.55
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
-$0.37 per share
Actual
-$0.39 per share
Replay Earnings Call

You May Also Like

GSMGW
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure